New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
15:09 EDTHIG, EW, YUM, LIFE, GILD, TMK, LEG, APCCompanies reporting After the Market Close on Monday, February 4
Notable companies reporting after the bell include Anadarko Petroleum (APC), Gilead Sciences (GILD), Edwards Lifesciences (EW), Leggett & Platt (LEG), Life Technologies (LIFE), The Hartford Financial Services Group (HIG), Torchmark (TMK) and Yum! Brands (YUM).
News For APC;GILD;EW;LEG;LIFE;HIG;TMK;YUM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 1, 2015
18:20 EDTAPCShell CEO says Opec production has pressured shale companies, FT reports
In an interview with the Financial Times, Shell (RDS.A, RDS.B) CEO Ben van Beurden said Opec's decision not to cut production has sent a "powerful signal... to shale oil companies as well as their financiers that they cannot forget the price risk. The industry will remember it for some time." The CEO noted that industry efforts to boost efficiency and cut costs should keep production going for "a while to come... until the sweet spots start running out." Publicly traded companies in the space include Chevron (CVX), Anadarko Petroleum (APC), Exxon Mobil (XOM), BP (BP), Marathon Oil (MRO), BHP Billiton (BHP), ConocoPhillips (COP), Pioneer Natural Resources (PXD), EOG Resources (EOG), Concho (CXO), Whiting Petroleum (WLL), and Continental Resources (CLR). Reference Link
16:33 EDTGILDGilead submits NDA to FDA for single tablet regimen for HIV containing R/F/TAF
Gilead Sciences (GILD) announced that it has submitted a New Drug Application, or NDA, to the FDA for an investigational, once-daily single tablet regimen that combines Gileadís emtricitabine 200 mg and tenofovir alafenamide, or TAF, 25 mg with rilpivirine 25 mg, or R/F/TAF, from Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ), for the treatment of HIV-1 infection in adult and pediatric patients 12 years of age and older. The data submitted in the NDA support the use of R/F/TAF among patients who are HIV treatment-naÔve or who are virologically suppressed and want to replace their current antiretroviral treatment regimen. A Priority Review voucher acquired from Knight Therapeutics in November 2014 was submitted to the FDA along with the R/F/TAF NDA. Under the Prescription Drug User Fee Act, or PDUFA, the anticipated target action date for the R/F/TAF NDA is six months after the FDAís acceptance of the filing. TAF is a novel, investigational nucleotide reverse transcriptase inhibitor, or NRTI, that has demonstrated high antiviral efficacy at a dose less than one-tenth that of Gileadís Viread, as well as improved renal and bone laboratory parameters as compared to TDF in clinical trials in combination with other antiretroviral agents. In addition to R/F/TAF, two other TAF-based HIV treatments are also under FDA review.
12:55 EDTHIGHartford Financial calls active on ACE Limited acquisition of Chubb
Subscribe for More Information
11:19 EDTAPCAnadarko July calls active on renewed takeover chatter
Subscribe for More Information
11:11 EDTYUMAnalyst says Yum! Brands could create value with China spin-off
There is a good chance that Yum! Brands could spin off its China business, adding value to its stock, UBS wrote in a note to investors earlier today. WHAT'S NEW: Activist investors will probably push Yum! to take steps to enhance its value and one of the moves the company is most likely to make is spinning off its China business, UBS analyst Keith Siegner wrote in a note to investors today. Following the spin-off of the China business, the rest of Yum, dubbed "Yum Global" by the analyst, could increase its leverage to 5-6 times and use the proceeds for share repurchases, Siegner believes. Meanwhile, the China business, which he calls "Yum China," would be a direct play on the growth of the Chinese middle class via a company that uses Western accounting standards, the analyst stated. Siegner believes that Yum Global's profits will grow by around low teen percentage levels, while those of Yum China will expand at a high teens/low twenties percentage rate. The analyst estimated that Yum Global would be worth $76 per share and Yum China would be worth $40 per share, leading him to increase his price target on Yum's current shares to $116 from $100. He kept a Buy rating on the stock. PRICE ACTION: In morning trading, Yum rose 1.5% to to $91.40.
11:04 EDTAPCRumor: Anadarko moves up on renewed takeover chatter
Subscribe for More Information
07:36 EDTYUMYum! Brands potential China separation an important catalyst, says UBS
Subscribe for More Information
June 30, 2015
11:58 EDTGILDStocks with call strike movement; GILD YHOO
Gilead (GILD) November 130 call option implied volatility increased 2% to 28, Yahoo (YHOO) October 46 call option implied volatility decreased 2% to 29 according to IVolatility.
09:35 EDTGILDActive equity options trading on open
Active equity options trading on open: AAPL FB GILD BABA BAC MU WYNN MSFT NFLX
07:32 EDTGILDJuno pact leaves Celgene set for growth past Revlimid, says Deutsche Bank
Subscribe for More Information
June 29, 2015
16:30 EDTGILDFDA sued by advocacy groups for Gilead Hep-C drug trial data, Reuters says
Subscribe for More Information
10:14 EDTAPCBP, Anadarko penalty appeals rejected by Supreme Court, Reuters reports
Subscribe for More Information
09:36 EDTAPCBP, Anadarko appeals on penalties rejected by Supreme Court, Reuters reports
The companies were rejected on appeals to avoid clean water act penalties related to the Deepwater Horizon spill, Reuters said.
June 25, 2015
11:50 EDTAPCAnadarko, Jera in talks over Mozambique long-term gas import deal, Reuters says
Subscribe for More Information
09:34 EDTGILDActive equity options trading on open
Active equity options trading on open: AAPL FB NFLX AMZN BAC CVX TWTR INTC GILD BBBY
June 23, 2015
14:10 EDTGILDGilead price target raised to $150 from $130 at Argus
Subscribe for More Information
11:20 EDTEWMedtronic competitive with Edwards after approval, says Wells Fargo
Subscribe for More Information
07:25 EDTEWPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
07:17 EDTEWFeedback on Edwards Lifesciences Centera 'very positive,' says Wells Fargo
Subscribe for More Information
June 22, 2015
09:40 EDTGILDActive equity options trading on open
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use